Robin W. Spencer

2.9k total citations · 1 hit paper
44 papers, 2.5k citations indexed

About

Robin W. Spencer is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Robin W. Spencer has authored 44 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Robin W. Spencer's work include Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (6 papers) and Click Chemistry and Applications (6 papers). Robin W. Spencer is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (6 papers) and Click Chemistry and Applications (6 papers). Robin W. Spencer collaborates with scholars based in United States, Canada and United Kingdom. Robin W. Spencer's co-authors include Christopher T. Walsh, Jed F. Fisher, Allen Krantz, Leslie J. Copp, Fredric J. Vinick, R. Michael Snider, Manoj C. Desai, Wesley Lebel, Kelly P. Longo and John Lowe and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Robin W. Spencer

44 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Potent Nonpeptide Antagonist of the Substance P (NK ₁ ) Receptor

1991 727 citations Robin W. Spencer et al. profile →

Peers

Robin W. Spencer

CMN

PHYSI

ONCOL

William H. Parsons United States

Wolfgang Nastainczyk Germany

William Bourguet France

Vincenzo Santagada Italy

Yafeng Xue Sweden

Roland E. Dolle United States

Dana L. Johnson United States

Mark Thomas United Kingdom

Giuseppe Caliendo Italy

Kathleen Coll United States

William H. Parsons United States

Robin W. Spencer

2.5k ×1.9

306 ×0.5

CMN

810 ×1.5

361 ×1.4

PHYSI

358 ×1.5

ONCOL

Citations per year, relative to Robin W. Spencer Robin W. Spencer (= 1×) peers William H. Parsons

Countries citing papers authored by Robin W. Spencer

Since Specialization

Citations

This map shows the geographic impact of Robin W. Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin W. Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin W. Spencer more than expected).

Fields of papers citing papers by Robin W. Spencer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin W. Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin W. Spencer. The network helps show where Robin W. Spencer may publish in the future.

Co-authorship network of co-authors of Robin W. Spencer

This figure shows the co-authorship network connecting the top 25 collaborators of Robin W. Spencer. A scholar is included among the top collaborators of Robin W. Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin W. Spencer. Robin W. Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spencer, Robin W.. (2013). Work Is Not a Game. Research-Technology Management. 56(6). 59–60. 5 indexed citations

Spencer, Robin W.. (2012). Open Innovation in the Eighteenth Century. Research-Technology Management. 55(4). 39–43. 7 indexed citations

Benson, Neil, Helen Boyd, Jeremy R. Everett, et al.. (2005). NanoStore: A Concept for Logistical Improvements of Compound Handling in High-Throughput Screening. SLAS DISCOVERY. 10(6). 573–580. 13 indexed citations

Martin, William H., et al.. (1999). The Use of β,γ-Methyleneadenosine 5′-Triphosphate to Determine ATP Competition in a Scintillation Proximity Kinase Assay. Analytical Biochemistry. 271(2). 131–136. 6 indexed citations

Faraci, W. Stephen, et al.. (1995). Inhibition of Helicobacter pylori Urease by Phenyl Phosphorodiamidates: Mechanism of Action. Bioorganic & Medicinal Chemistry. 3(5). 605–610. 46 indexed citations

Faraci, W. Stephen, Robin W. Spencer, Rebecca Williams, et al.. (1993). Inhibition of human leukocyte elastase (HLE) by novel bicyclic β-lactams. Bioorganic & Medicinal Chemistry Letters. 3(11). 2271–2276. 6 indexed citations

Hauske, James R., et al.. (1992). Design and synthesis of novel FKBP inhibitors. Journal of Medicinal Chemistry. 35(23). 4284–4296. 24 indexed citations

Purwantini, Endang, Biswarup Mukhopadhyay, Robin W. Spencer, & Lacy Daniels. (1992). Effect of temperature on the spectral properties of coenzyme F420 and related compounds. Analytical Biochemistry. 205(2). 342–350. 30 indexed citations

Krantz, Allen, Robin W. Spencer, Tim F. Tam, et al.. (1990). Design and synthesis of 4H-3,1-benzoxazin-4-ones as potent alternate substrate inhibitors of human leukocyte elastase. Journal of Medicinal Chemistry. 33(2). 464–479. 237 indexed citations

10.

Geoghegan, Kieran F., Robin W. Spencer, Dennis E. Danley, Leonard G. Contillo, & Glenn C. Andrews. (1990). Fluorescence‐based continuous assay for the aspartyl protease of human immunodeficiency virus‐1. FEBS Letters. 262(1). 119–122. 22 indexed citations

11.

Smith, Roger A., Peter J. Coles, Robin W. Spencer, et al.. (1988). Peptidyl O-acyl hydroxamates: Potent new inactivators of cathepsin B. Biochemical and Biophysical Research Communications. 155(3). 1201–1206. 33 indexed citations

12.

Smith, Roger A., Leslie J. Copp, Peter J. Coles, et al.. (1988). New inhibitors of cysteine proteinases. Peptidyl acyloxymethyl ketones and the quiescent nucleofuge strategy. Journal of the American Chemical Society. 110(13). 4429–4431. 53 indexed citations

13.

Smith, Roger A., et al.. (1988). Inhibition of cathepsin B by peptidyl aldehydes and ketones: slow-binding behavior of a trifluoromethyl ketone. Biochemistry. 27(17). 6568–6573. 44 indexed citations

14.

Krantz, Allen, Robin W. Spencer, Tim F. Tam, Everton M. Thomas, & Leslie J. Copp. (1987). Design of alternate substrate inhibitors of serine proteases. Synergistic use of alkyl substitution to impede enzyme-catalyzed deacylation. Journal of Medicinal Chemistry. 30(4). 589–591. 27 indexed citations

15.

Spencer, Robin W., Leslie J. Copp, & Jürg R. Pfister. (1985). Inhibition of human leukocyte elastase, porcine pancreatic elastase, and chymotrypsin by elasnin and other 4-hydroxy-2-pyrones. Journal of Medicinal Chemistry. 28(12). 1828–1832. 31 indexed citations

16.

Tam, Tim F., Robin W. Spencer, Everton M. Thomas, Leslie J. Copp, & Allen Krantz. (1984). Novel suicide inhibitors of serine proteinases. Inactivation of human leukocyte elastase by ynenol lactones. Journal of the American Chemical Society. 106(22). 6849–6851. 26 indexed citations

17.

Nagahisa, Atsushi, Robin W. Spencer, & William H. Orme‐Johnson. (1983). Acetylenic mechanism-based inhibitors of cholesterol side chain cleavage by cytochrome P-450scc.. Journal of Biological Chemistry. 258(11). 6721–6723. 31 indexed citations

18.

Walsh, Christopher T., Jed F. Fisher, Robin W. Spencer, et al.. (1978). Chemical and enzymic properties of riboflavin analogs. Biochemistry. 17(10). 1942–1951. 125 indexed citations

19.

Spencer, Robin W., Jed F. Fisher, & Christopher T. Walsh. (1977). One- and two-electron redox chemistry of 1-carba-1-deazariboflavin. Biochemistry. 16(16). 3586–3594. 42 indexed citations

20.

Spencer, Robin W., Jed F. Fisher, & Christopher T. Walsh. (1976). Preparation, characterization, and chemical properties of the flavin coenzyme analogues 5-deazariboflavin, 5-deazariboflavin 5'-phosphate, and 5-deazariboflavin 5'-diphosphate, 5' → 5'-adenosine ester. Biochemistry. 15(5). 1043–1053. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact